TELUS (TU) Q1 2026 earnings review
Free Cash Flow Shines While Core Mobile Metrics Show Cracks
TELUS delivered a mixed Q1 2026. While management celebrated 'industry-leading' total customer growth of 262,000, looking under the hood reveals that mobile phone net additions fell to just 12,000 as churn spiked. GAAP Net Income collapsed 52% year-over-year to $144M, battered by escalating restructuring costs. However, the cash engine remains highly intact—Free Cash Flow surged 19% to $583M, providing ample coverage for the dividend and deleveraging targets. The bright spots are the non-telecom verticals: TELUS Health maintained double-digit growth, and the new Sovereign AI factories are already selling out capacity.
🐂 Bull Case
Free Cash Flow grew 19% to $583M, keeping TELUS on a comfortable glide path to its ~$2.45B annual target. This underpins the company's ability to hit its aggressive 3.3x leverage target by year-end 2026.
The first Sovereign AI Factory in Rimouski sold out within months of launch. With Kamloops coming online next, AI is proving to be a highly capital-efficient growth vector with immediate market demand.
🐻 Bear Case
Mobile phone churn spiked from 1.06% in 25Q1 to 1.35% in 26Q1 due to intense promotional activity. Despite gross additions surging by 89,000, net additions dropped to a meager 12,000.
Restructuring and other costs ballooned to $315M in the quarter (up from $93M a year ago). Management also raised the full-year restructuring cost assumption from $500M to $600M, wiping out bottom-line profitability.
⚖️ Verdict: ⚪
Neutral. TELUS is executing flawlessly on its non-core tech bets (Health, AI) and cash generation. However, the aggressive promotional macro environment in Canadian telecom is actively eroding its premium core mobile base, resulting in reversing net income and a troubling churn spike.
Key Themes
Customer Growth Narrative Masks Mobile Phone Weakness
Management touted 262,000 total mobile and fixed net additions as 'industry-leading'. However, the specific data contradicts this positive narrative for the core business: 229,000 of those additions were lower-value connected devices. High-margin mobile phone net additions were only 12,000, decelerating from 20,000 a year ago, primarily because churn spiked dramatically to 1.35%.
Sovereign AI Factories Transition from Concept to Revenue
TELUS's capital-efficient AI strategy is showing immediate commercial success. The Sovereign AI Factory in Rimouski, Quebec—Canada's first fully sovereign AI facility—is now completely sold out. The company is actively expanding compute inventory there and bringing a second facility in Kamloops online shortly to capture surging domestic AI demand.
TELUS Health Continues Double-Digit Ascent
TELUS Health remains a stable, accelerating growth engine. Operating revenues grew 11% to $524M, and Adjusted EBITDA grew 11% to $93M. The segment now covers nearly 170 million lives globally, capturing organic growth in employee and family assistance programs (EFAP) alongside the ongoing realization of integration synergies from Workplace Options.
Monetization of TELUS Health Explored
Following the successful Terrion tower transaction last year, management confirmed they are conducting a 'comprehensive review of strategic partnership opportunities for TELUS Health' with financial advisors. Any proceeds will be deployed directly toward deleveraging, establishing a clear catalyst for balance sheet improvement.
Mobile Phone ARPU Decline Decelerating, But Still Negative
Mobile phone ARPU was $56.56, down 1.0% YoY. While this represents a decelerating rate of decline compared to the -3.3% to -1.6% drops seen throughout 2025, it still confirms that the Canadian macro environment remains highly promotional, forcing customers into lower-priced base plans.
Mobile Equipment Revenues Drop Sharply
Mobile equipment and other service revenues declined by $50M (-10%) to $474M in Q1. This reversing trend signals a significant reduction in contracted device upgrade volumes as consumer spending tightens, only partially offset by a shift toward higher-value smartphones in the mix.
Aggressive Cost Synergy Execution
The integration of TELUS Digital following its privatization is already tracking against its plan to deliver $150M-$200M in annual cash synergies. The company realized annualized free cash flow synergies of ~$115M by the end of Q1 2026, protecting Adjusted EBITDA margins amid flat revenue.
Other KPIs
Accelerating significantly from $93 million in 25Q1. This massive expense relates to cost efficiency programs, the privatization of TELUS Digital, and workforce reductions. Management also increased their full-year 2026 cash restructuring disbursements guidance from ~$450M to ~$550M, indicating that the pain on the GAAP income statement will persist throughout the year.
Stable. Grew 1% YoY, driven by TELUS Health, subscriber base growth, and higher residential internet revenue per customer, which successfully offset declines in legacy voice and mobile ARPU compression. Demonstrates the resilience of the bundled pricing strategy.
Accelerating. Up 11% YoY from $587M, primarily driven by investments in new facilities to meet industry demand and multi-year real estate development projects like TELUS Ocean. Despite this Q1 bump, full-year guidance still calls for a 10% decrease.
Guidance
Accelerating vs the 1% growth achieved in 26Q1. This implies an expectation of improved wireless monetization or stronger enterprise cross-selling in the back half of the year.
Accelerating vs the flat (0%) growth reported in 26Q1. Achieving this will require heavy reliance on the $150M-$200M in TELUS Digital cash synergies scaling up through the year.
Stable. Represents ~10% growth over FY25's $2.2 billion record. Driven by expected EBITDA growth and lower capital intensity. 26Q1 results ($583M) suggest they are tracking comfortably to this target.
Decelerating. Implies a ~10% decrease from FY25. With $651M already spent in Q1, the run-rate for the remaining three quarters will need to drop to ~$550M per quarter.
Improving. The company is charting a clear path down from the 3.4x level seen at the end of FY25, aiming for 3.0x or better by YE2027. Potential TELUS Health monetization would severely accelerate this timeline.
Key Questions
Mobile Churn Trajectory
Mobile phone churn spiked to 1.35% due to competitive switching. What specific tactical adjustments are being made to defend the premium base, and when do you expect churn to normalize back toward historical sub-1% levels?
TELUS Health Monetization Mechanics
You noted advisors are exploring strategic partnerships for TELUS Health. Are you looking at a partial equity sale similar to the Terrion tower deal, or a complete divestiture, and what is the timeline for a decision?
Capital Expenditure Phasing
CapEx grew 11% to $651M in Q1, yet your full-year guidance calls for a 10% decline to $2.3B. What specific capital programs are being turned off or delayed in Q2-Q4 to achieve this sharp deceleration in spend?
Sovereign AI Factory Economics
With the Rimouski AI facility sold out, what is the margin profile of these AI compute revenues compared to traditional enterprise cloud or digital services, and how much CapEx is required to stand up the Kamloops facility?